current glp 1 drugs GLP-1 Drugs: 6 Things We've Learned About Their Effects How GLP-1 medications are transforming

Do No Harm: Managing Nausea and Vomiting in GLP-1 Based Obesity Therapies

Before this approval, only branded GLP-1 drugs, including Saxenda and Wegovy (semaglutide), were available for weight loss, limiting patient access

It affects the GLP one receptor but also the GIP receptor, which are both involved in hunger and satiety and motility. Dan Azagury, MD, FACS, the chief bariatric surgeon and medical director of Stanford University School of Medicines Lifestyle and Weight Management Clinic in California, who also was not involved in the Eli Lilly study, told Healthline that he was not surprised at the studys results

[DOI] [PMC free article] [PubMed] [Google Scholar] 93.The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: scandinavian cohort study

However, when starting a GLP-1 agonist in someone already on basal insulin, the insulin dose often needs to be reduced by 10 to 20 percent to prevent hypoglycemia